BRD2 and cardiac hypertrophy: In conclusion, the present study identified BRD2 as a novel regulator of pathological cardiac hypertrophy, which could facilitate cardiac hypertrophy through upregulating gene expression of cardiac metabolic enzymes in particular those in TCA cycle.